Individualized immunotherapies are a beacon of hope in cancer research. The purpose of the non-profit IOZK Foundation is to promote the scientific basis of immune-oncological research. We support translational medicine that makes discoveries of immunologic base research available to cancer patients. Modern immunotherapies have less side effects than chemotherapy and radiotherapy, thanks to their higher tumor specificity.

Further information can be found on the website of the IOZK Foundation: www.iozk-stiftung.org as well as on the website of the centre: www.iozk.de/en